Here is an article discussing ocular allergies. The test for ocular allergies is an in-office procedure the Eye Institute of West Florida #eyeinstituteofwestflorida conduct testing for 58 allergens. #allergydiagnostics The nice thing about this FDA approved test is that the results are quick and the treatment discussion is the same day. Understanding ocular allergies begins with proper diagnosis (allergy diagnostics). With over 24 million suffers of ocular allergies, Dr. Robert Weinstock #drrobertweinstock and Dr. Neel Desai #drneeldesai are able to administer a non-invasive, no-needle, regionally specific test designed to objectively diagnose allergies. This FDA approved test is covered and reimbursed by all major medical insurances and Medicare. Results are interpreted within 10 to 15 minutes. The consultation that follows helps patients understand their sensitive allergens and methods of avoidance.
New diagnostics may be a boon to both patient care and practice development.
Neel R. Desai, MD, and Robert J. Weinstock, MD, Largo, Fla.
Until recently, the treatment of ocular surface diseases, including allergic conjunctivitis, dry-eye syndrome and other ocular surface inflammatory diseases, lay frozen in the dark ages of ophthalmic care and science. Whole generations of ophthalmologists and eye-care professionals had been indoctrinated in to a mode of thinking about ocular surface diseases that amounted to treating such patients dismissively with little more than palliative care.
However, in just the last five to 10 years we have been witness to a veritable renaissance in not only the available diagnostic and treatment modalities but, perhaps more critically, the value practitioners place on attentively diagnosing and treating these diseases. We can, in part, credit the merger of the refractive and cataract worlds with placing these otherwise minor issues closer to the forefront of surgeons’ considerations as they play a major role in achieving precision outcomes and maintaining high levels of patient satisfaction.
This paradigm shift represents a boon for first and foremost, good medicine and patient care but also for practice growth and development. In this article, we wish to share with you our experiences with some of the newer diagnostic modalities, specifically ocular allergy testing, that have benefited our patients and, in turn, our practice.
The Shotgun Approach
If we are to be honest with ourselves, when faced with a red, irritated set of eyes, many practitioners might reflexively treat with a “shotgun” approach—often recommending artificial tears, a favored antibiotic-steroid drop, and/or antihistamine, without so much as a fleeting thought about true underlying etiology. Studies showing that up to 20 percent of patients with ocular surface disease complaints have undiagnosed and significant systemic diseases, underline our collective failure to systematically tease apart the potential separate but additive contributions of allergic processes, aqueous tear insufficiency, meibomian gland and lid margin disease, infectious processes, or other pro-inflammatory states from one another.1 Does a patient with ocular irritation simply have dry eyes or does she also have ocular rosacea-driven lid margin disease, poor meibomian gland function, and hence tear-film instability? Does the patient with chronic redness and vague irritation have dry eyes alone, or an underlying systemic inflammatory condition? Are ocular allergies playing a role in either of these very common clinical circumstances? How can we expect to adequately respond to each patient’s unique mix of complaints if we don’t make an effort to uncover the constellation of problems that contribute to the overall disease state? The answer to these questions is quite simply, “Seek and ye shall find.”
Read the rest of the article: http://bit.ly/SDHGhb
Robert J. Weinstock, M.D. is a board-certified ophthalmologist and is fellowship-trained in cataract and refractive surgery. He became interested in ophthalmology at an early age – as he watched and assisted his father. Dr. Weinstock has joined the practice in 2001 after completing his residency at the St. Louis University School of Medicine. He is the Director of Cataract and Refractive Services at the Eye Institute of West Florida and The Weinstock Laser Eye Center. #eyeinstituteofwestflorida He also is an associate clinical professor of ophthalmology at the University of South Florida, and serves as the Surgical Director of the Largo Ambulatory Surgery Center. He was named one of 250 in Premier Surgeon’s List of Leading Innovators of 2010 for his contributions to cataract surgery and premium IOLs. In addition to performing thousands of vision correcting cataract and LASIK #lasiksurgery procedures each year, Dr. Weinstock speaks and teaches nationally and internationally on customized cataract surgery and surgical innovations. He is continuously engaged in clinical research and studies to evaluate new technology, many of which are sanctioned by the FDA. He #drrobertweinstock is recognized internationally as an expert on new implant technology and microincisional surgical techniques. He has authored many book chapters on cataract surgery and continues to write journal articles on cataract and refractive surgery.
Undergraduate: Brandeis University, Waltham, MA
Medical School: The Chicago Medical School, IL
Internship: St. John’s Mercy Medical Center, St. Louis, MO
Residence: St. Louis University School of Medicine, MO
Fellowship: The Eye Institute of West Florida
Board Certifications: American Board of Ophthalmology, Cataract Certification (Sub-Specialty) Cataract/Implant Surgery, American Board of Eye Surgery, LASIK Certification (Sub-Specialty) Refractive Surgery
Academic Appointment: Assistant Clinical Professor, Department of Ophthalmology, University of South Florida, Tampa
Specialty: Refractive Cataract & LASIK Surgery
Robert J. Weinstock, MD, can be reached at Eye Institute of West Florida, 148 13th St. NW, Largo, FL 33770; 727-581-8706; or at http://cataractsurgeons.com for a consultation. email: email@example.com.
Specialty: Refractive Cataract, Cornea & LASIK Surgery
Neel R. Desai, M.D. #drneeldesai is a fellowship-trained ophthalmologist strictly specializing in LASIK, cataract and corneal diseases of the eye. Dr. Desai is a top graduate of the Pennsylvania State University College of Medicine and completed his fellowship in cornea, cataract and refractive surgery at the Wilmer Eye Institute at Johns Hopkins University. He is recognized throughout the country and internationally as one of only 100 surgeons able to perform advanced corneal transplants and other complex cataract, corneal and refractive procedures. He holds pending patents to new surgical products and advanced cornea surgical procedures of his own design. Additionally, Dr. Desai has authored many book chapters in his field of study and continues to write articles in peer review journals. #cornea
Joined the Practice: 2008
Place of Birth: Baltimore, MD
Undergraduate: University of Maryland, Baltimore
Medical School: Pennsylvania State University College of Medicine, Hershey
Internship: Medical University of South Carolina, Charleston
Residency: Storm Eye Institute, Medical University of South Carolina, Charleston
Fellowship: Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD
Board Certification: American Board of Ophthalmology Eligible
Academic Appointment: Staff Physician, Wilmer Eye Institute, Johns Hopkins Hospital
You can reach Dr. Desai at 727-581-8706 or at http://cataractsurgeons.com for a consultation.